Skip to content

Informative Exhibition for Deprescribing Benzodiazepines

Impact of an Interactive and Informative Exhibition on Benzodiazepine Use on Deprescription.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06467019
Acronym
ESUB
Enrollment
6410
Registered
2024-06-20
Start date
2024-06-13
Completion date
2026-07-31
Last updated
2025-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benzodiazepine-Related Disorders

Keywords

Benzodiazepines, Deprescriptions

Brief summary

The goal of this trial is to determine if an interactive and informative exhibition in the waiting room of a Primary Care Clinic can reduce the use of benzodiazepines in adults. The main question it aims to answer is: • Does an interactive and informative exhibition reduce the number of participants using benzodiazepines? Researchers will compare benzodiazepine consumption before and after the interactive and informative exhibition implementation at study center. Participants will receive an informative and interactive exhibition on the risks of chronic benzodiazepine use. A single informative session on the same topic will be conducted for health professionals.

Interventions

OTHERInformative Session

The intervention consists of implementing an interactive exhibition on the risks of chronic benzodiazepine treatment in the waiting room of a primary care center. Additionally, the health professionals at the center will receive a single informative session on the same topic.

Sponsors

Consorci Sanitari de l'Alt Penedès i Garraf
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Men and women between 18 and 99 years of age. * Attended at the Baix-a-Mar Primary Care Center during the study period.

Exclusion criteria

* Severe mental health disease * Displaced patients or those who do not have an assigned doctor at the center. * Participation in another study involving an experimental intervention during the period of the present study that affects benzodiazepine prescription.

Design outcomes

Primary

MeasureTime frameDescription
Chronic treatment with benzodiazepines1 yearPercentage of patients treated chronically with benzodiazepines, based on electronic prescription data.

Countries

Spain

Contacts

Primary ContactJordi Milozzi, MD
jmilozzi@csapg.cat+34 938 10 30 03
Backup ContactNoemí Casaponsa
recerca@csapg.cat+34 938960025

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026